title: [New and established indications for phototherapy with narrowband UVB].
abstract: Phototherapy with ultraviolet (UV) irradiation of wavelengths between 280 and 320 nm (UV-B) is a safe and effective treatment for a variety of inflammatory skin diseases. In addition to standard broad band UVB, narrow band phototherapy with fluorescent bulbs emitting near monochromatic UV between 310-315 nm has become an important treatment for diseases such as psoriasis, atopic dermatitis or vitiligo. Other diseases respond favorably to narrow band UV-B phototherapy, the number of potential indications for such phototherapy is continuously growing. The differential effects of narrow band UV-B phototherapy in comparison to other UV phototherapies, as well as new and established indications for this treatment modality are reviewed.
authors.affiliation: Universitäts-Hautklinik, Eberhard-Karls-Universität Tübingen, Liebermeisterstrasse 25, D-72076 Tübingen, Germany. Mark.Berneburg@med.uni-tuebingen.de
authors.forename: Mark
authors.initials: M
authors.lastname: Berneburg
authors.forename: Corinna
authors.initials: C
authors.lastname: Brod
authors.forename: Frauke
authors.initials: F
authors.lastname: Benedix
authors.forename: Martin
authors.initials: M
authors.lastname: Röcken
mesh_terms: D006801:Humans; D011701:PUVA Therapy / Q000379:methods; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012871:Skin Diseases / Q000532:radiotherapy*; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*
chemical_list: D011838:Radiation-Sensitizing Agents